newsfilter
← Latest News
GlobeNewswire·

Alvotech Secures Settlement Agreement in Global Markets for its Biosimilar to Eylea® 2mg

REYKJAVIK, Iceland, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ:ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today